Abstract
A novel series of 3,4-diphenyl-7-(hetero)arylimidazo[2,1-\(c\)][1,2,4]triazin-6-amine derivatives were synthesized via three-component reaction of 5,6-diphenyl-1,2,4-triazin-3-amine, various aromatic aldehydes, and cyclohexyl isocyanide. All synthesized compounds were tested against HL60 (human promyelocytic leukemia), MOLT-4 (human T lymphoblastic leukemia), and MCF-7 (human breast adenocarcinoma) cell lines, as cytotoxic agents. The structure–activity relationships study revealed that the introduction of hydroxyl and methoxy groups on the 7-phenyl ring can modulate the cytotoxic activity of these compounds. Among the 7-aryl derivatives, 3-hydroxyphenyl and 3-hydroxy-4-methoxyphenyl derivatives (6h and 6o) were the most potent compounds against HL60 and MCF-7 cells (\(\hbox {IC}_{50}\hbox {s} = 9.8-20.4\;\upmu \)M). However, the replacement of the 7-aryl moiety with pyridyl or furan-2-yl resulted in compounds 6p or 6r with more promising cytotoxicity against MOLT-4 cell line (\(\hbox {IC}_{50}\) values 12.1 and 13.0 \(\upmu \)M, respectively). Also, the acridine orange/ethidium bromide staining assay in MCF-7 cells suggested that the cytotoxic activity of compound 6r occurs via apoptosis.
Similar content being viewed by others
References
Pau A, Murineddu G, Asproni B, Murruzzu C, Grella GE, Pinna GA, Curzu MM, Marchesi I, Bagella L (2009) Synthesis and cytotoxicity of novel hexahydrothienocycloheptapyridazinone derivatives. Molecules 14:3494–3508. doi:10.3390/molecules14093494
Fidler IJ (2003) The pathogenesis of cancer metastasis: the ’seed and soil’ hypothesis revisited. Nat Rev Cancer 3:453–458. doi:10.1038/nrc1098
Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics. CA Cancer J Clin 57:43–66. doi:10.3322/canjclin.57.1.43
Liu YQ, Ohkoshi E, Li LH, Yang L, Lee KH (2012) Design, synthesis and cytotoxic activity of novel spin-labeled rotenone derivatives. Bioorg Med Chem Lett 22:920–923. doi:10.1016/j.bmcl.2011.12.024
Nakhjiri M, Safavi M, Alipour E, Emami S, Atash AF, Jafari-Zavareh M, Ardestani SK, Khoshneviszadeh M, Foroumadi A, Shafiee A (2012) Asymmetrical 2,6-bis(benzylidene)cyclohexanones: synthesis, cytotoxic activity and QSAR study. Eur J Med Chem 50:113–123. doi:10.1016/j.ejmech.2012.01.045
Das JR, Fryar-Tita EB, Green S, Southerland WM, Bowen D (2007) Sequence-dependent administration of raloxifene and 5-fluorouracil/pemetrexed protects against pemetrexed cytotoxicity in human bone marrow. Anticancer Res 27:825–833
Shaw AY, Liau HH, Lu PJ, Yang CN, Lee CH, Chen JY, Xu Z, Flynn G (2010) 3,5-Diaryl-\(1H\)-pyrazole as a molecular scaffold for the synthesis of apoptosis-inducing agents. Bioorg Med Chem 18:3270–3278. doi:10.1016/j.bmc.2010.03.016
Zhang D, Wang G, Zhao G, Xu W, Huo L (2011) Synthesis and cytotoxic activity of novel 3-(\(1H\)-indol-3-yl)-\(1H\)-pyrazole-5-carbohydrazide derivatives. Eur J Med Chem 46:5868–5877. doi:10.1016/j.ejmech.2011.09.049
Chen Z, Cao R, Yu L, Shi B, Sun J, Guo L, Ma Q, Yi W, Song X, Song H (2010) Synthesis, cytotoxic activities and DNA binding properties of \(\beta \)-carboline derivatives. Eur J Med Chem 45:4740–4745. doi:10.1016/j.ejmech.2010.07.037
Baviskar AT, Madaan C, Preet R, Mohapatra P, Jain V, Agarwal A, Guchhait S, Kundu CN, Banerjee UC, Bharatam PV (2011) N-fused imidazoles as novel anticancer agents that inhibit catalytic activity of topoisomerase II\(\alpha \) and induce apoptosis in G1/S Phase. J Med Chem 54:5013–5030. doi:10.1021/jm200235u
Labouta IM, Eshba NH, Salama HM (1988) Synthesis of some substituted triazolo[4,3-b][1,2,4]triazines as potential anticancer agents. Monatsh Chem 119:591–596. doi:10.1007/BF00809211
Kumar R, Gupta L, Pal P, Khan S, Singh N, Katiyar SB, Meena S, Sarkar J, Sinha S, Kanaujiya JK, Lochab S, Trivedi AK, Chauhan PM (2010) Synthesis and cytotoxicity evaluation of (tetrahydro-\(\beta \)-carboline)-1,3,5-triazine hybrids as anticancer agents. Eur J Med Chem 45:2265–2276. doi:10.1016/j.ejmech.2010.02.001
Saczewski F, Bulakowska A, Bednarski P, Grunert R (2006) Synthesis, structure and anticancer activity of novel 2,4-diamino-1,3,5-triazine derivatives. Eur J Med Chem 41:219–225. doi:10.1016/j.ejmech.2005.10.013
Eshba NH, Salama HM, Labouta IM, Omar AM (1987) Synthesis of some substituted 1,2,4-triazino[5,6-\(b\)]indole derivatives as potential antiviral and anticancer agent. Pharmazie 42:664–666
Labouta IM, Soliman FSG, Kassem MG (1986) Some substituted imidazo[1,2-\(b\)][1,2,4]triazines and 8\(H\)-pyrimido[1,2-\(b\)][1,2,4]triazin-8-ones as potential antineoplastic agents. Pharmazie 41:812–813
Fallah-Tafti A, Foroumadi A, Tiwari R, Shirazi AN, Hangauer DG, Bu Y, Akbarzadeh T, Parang K, Shafiee A (2011) Thiazolyl \(N\)-benzyl-substituted acetamide derivatives: synthesis, Src kinase inhibitory and anticancer activities. Eur J Med Chem 46:4853–4858. doi:10.1016/j.ejmech.2011.07.050
Alipour E, Mousavi Z, Safaei Z, Pordeli M, Safavi M, Firoozpour L, Mohammadhosseini N, Saeedi M, Ardestani SK, Shafiee A, Foroumadi A (2014) Synthesis and cytotoxic evaluation of some new[1,3]dioxolo[4,5-\(g\)]chromen-8-one derivatives. Daru J Pharm Sci 22:41. doi:10.1186/2008-2231-22-41
Ketabforoosh SH, Kheirollahi A, Safavi M, Esmati N, Ardestani SK, Emami S, Firoozpour L, Shafiee A, Foroumadi A (2014) Synthesis and anti-cancer activity evaluation of new dimethoxylated chalcone and flavanone analogs. Arch Pharm (Weinheim). doi:10.1002/ardp.201400215
Zonouzi A, Mirzazadeh R, Safavi M, Ardestani SK, Emami S, Foroumadi A (2013) 2-Amino-4-(nitroalkyl)-4\(H\)-chromene-3-carbonitriles as new cytotoxic agents. Iran J Pharm Res 12:679–685
Letafat B, Shakeri R, Emami S, Noushini S, Mohammadhosseini N, Shirkavand N, Ardestani SK, Safavi M, Samadizadeh M, Letafat A, Shafiee A, Foroumadi A (2013) Synthesis and in vitro cytotoxic activity of novel chalcone-like agents. Iran J Basic Med Sci 16:1155–1162
Safavi M, Esmati N, Ardestani SK, Emami S, Ajdari S, Davoodi J, Shafiee A, Foroumadi A (2012) Halogenated flavanones as potential apoptosis-inducing agents: synthesis and biological activity evaluation. Eur J Med Chem 58:573–580. doi:10.1016/j.ejmech.2012.10.043
Rahmani-Nezhad S, Safavi M, Pordeli M, Ardestani SK, Khosravani L, Pourshojaei Y, Mahdavi M, Emami S, Foroumadi A, Shafiee A (2014) Synthesis, in vitro cytotoxicity and apoptosis inducing study of 2-aryl-3-nitro-\(2H\)-chromene derivatives as potent anti-breast cancer agents. Eur J Med Chem 86:562–569. doi:10.1016/j.ejmech.2014.09.017
Bienaymé H, Bouzid K (1998) A new heterocyclic multicomponent reaction for the combinatorial synthesis of fused 3-aminoimidazoles. Angew Chem Int Ed 37:2234–2237. doi:10.1002/(SICI)1521-3773(19980904)37:16<2234::AID-ANIE2234>3.0.CO;2-R
Mahdavi M, Asadi M, Saeedi M, Ebrahimi M, Rasouli MA, Ranjbar PR, Foroumadi A, Shafiee A (2012) One-pot, four-component synthesis of novel imidazo[2,1-\(b\)]thiazol-5-amine derivatives. Synthesis 44:3649–3654. doi:10.1055/s-0032-1317515
Musatov DM, Kurilov DV, Rakishev AK (2008) Efficient synthesis of 3-amino-5,6-diphenyl-1,2,4-triazine. Ukr Bioorg Acta 1:61–62
Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63. doi:10.1016/0022-1759(83)90303-4
Miri R, Motamedi R, Rezaei MR, Firuzi O, Javidnia A, Shafiee A (2011) Design, synthesis and evaluation of cytotoxicity of novel chromeno[4,3-\(b\)]quinoline derivatives. Arch Pharm 344:111–118. doi:10.1002/ardp.201000196
Renvoizé C, Biola A, Pallardy M, Bréard J (1998) Apoptosis: identification of dying cells. Cell Biol Toxicol 14:111–120. doi:10.1023/A:1007429904664
Acknowledgments
This research was supported by grants from the Research Council of Tehran University of Medical Sciences and Iran National Science Foundation (INSF).
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Akbarzadeh, T., Noushini, S., Taban, S. et al. Synthesis and cytotoxic activity of novel poly-substituted imidazo[2,1-\(c\)][1,2,4]triazin-6-amines. Mol Divers 19, 273–281 (2015). https://doi.org/10.1007/s11030-015-9566-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11030-015-9566-6